Class A · CUSIP G7709Q104 · who reports it, how much, and how much it matters to them
34 of the 720 hedge fund managers we track reported shares of Royalty Pharma plc (Nasdaq: RPRX) on Form 13F for 30 June 2026. Between them they reported USD 807m. The largest position belongs to Two Sigma Investments, at USD 164m. The manager with the most riding on it is Lion Point Capital, where it is 5.7% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Two Sigma Investments35 funds on PPLI.com | USD 164m | 0.1% |
| 2 | Adage Capital Management1 fund on PPLI.com | USD 140m | 0.2% |
| 3 | Marshall Wace LLP84 funds on PPLI.com | USD 137m | 0.1% |
| 4 | Renaissance Technologies13 funds on PPLI.com | USD 109m | 0.1% |
| 5 | Citadel Advisors32 funds on PPLI.com | USD 76m | 0.0% |
| 6 | Tudor Investment Corporation10 funds on PPLI.com | USD 34m | 0.0% |
| 7 | D. E. Shaw & Co.15 funds on PPLI.com | USD 29m | 0.0% |
| 8 | Arrowmark Colorado Holdings24 funds on PPLI.com | USD 21m | 0.9% |
| 9 | Squarepoint Ops7 funds on PPLI.com | USD 18m | 0.0% |
| 10 | Bridgewater Associates45 funds on PPLI.com | USD 12m | 0.1% |
| 11 | Engineers Gate Manager1 fund on PPLI.com | USD 7.7m | 0.1% |
| 12 | Dark Forest Capital Management2 funds on PPLI.com | USD 7.6m | 0.5% |
| 13 | CM Management1 fund on PPLI.com | USD 7m | 4.5% |
| 14 | IFM Investors Pty7 funds on PPLI.com | USD 7m | 0.0% |
| 15 | POINT72 Asset Management17 funds on PPLI.com | USD 6m | 0.0% |
| 16 | Brevan Howard Capital Management39 funds on PPLI.com | USD 4.6m | 0.0% |
| 17 | Verition Fund Management3 funds on PPLI.com | USD 4.2m | 0.0% |
| 18 | BTG Pactual Asset Management US11 funds on PPLI.com | USD 4m | 0.2% |
| 19 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 3m | 0.2% |
| 20 | Voloridge Investment Management6 funds on PPLI.com | USD 2.9m | 0.0% |
| 21 | Hudson Bay Capital Management8 funds on PPLI.com | USD 2.5m | 0.0% |
| 22 | CIBC Asset Management69 funds on PPLI.com | USD 1.9m | 0.0% |
| 23 | Sciencast Management1 fund on PPLI.com | USD 1.7m | 0.4% |
| 24 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 1.5m | 0.0% |
| 25 | Lion Point Capital1 fund on PPLI.com | USD 1.2m | 5.7% |
| 26 | Aquatic Capital Management3 funds on PPLI.com | USD 754,000 | 0.0% |
| 27 | Millennium Management6 funds on PPLI.com | USD 675,000 | 0.0% |
| 28 | Edgestream Partners5 funds on PPLI.com | USD 378,000 | 0.0% |
| 29 | Persistent Asset Partners10 funds on PPLI.com | USD 325,000 | 0.1% |
| 30 | Holocene Advisors2 funds on PPLI.com | USD 265,000 | 0.0% |
| 31 | Graham Capital Management18 funds on PPLI.com | USD 264,000 | 0.0% |
| 32 | Freestone Grove Partners1 fund on PPLI.com | USD 262,000 | 0.0% |
| 33 | Prelude Capital Management9 funds on PPLI.com | USD 241,000 | 0.0% |
| 34 | The Quarry1 fund on PPLI.com | USD 1,009 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Lion Point Capital | USD 1.2m | 5.7% |
| 2 | CM Management | USD 7m | 4.5% |
| 3 | Arrowmark Colorado Holdings | USD 21m | 0.9% |
| 4 | Dark Forest Capital Management | USD 7.6m | 0.5% |
| 5 | Sciencast Management | USD 1.7m | 0.4% |
| 6 | BTG Pactual Asset Management US | USD 4m | 0.2% |
| 7 | Adage Capital Management | USD 140m | 0.2% |
| 8 | Campbell & Company Investment Adviser | USD 3m | 0.2% |
| 9 | Renaissance Technologies | USD 109m | 0.1% |
| 10 | Two Sigma Investments | USD 164m | 0.1% |
Royalty Pharma plc trades under the symbol RPRX on the Nasdaq. Its CUSIP, the code used on Form 13F, is G7709Q104.
34 of the 720 hedge fund managers PPLI.com tracks reported Royalty Pharma plc shares on Form 13F for 30 June 2026. The largest reported positions were held by Two Sigma Investments (USD 164m), Adage Capital Management (USD 140m), Marshall Wace LLP (USD 137m), Renaissance Technologies (USD 109m) and Citadel Advisors (USD 76m).
34 managers in our coverage reported it, and between them they run 525 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Lion Point Capital, where the position was 5.7% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Royalty Pharma plc or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.